Exploration-Hypothesis Development Award – HT942524TSCRPEHDA
- up to USD$150,000 over 2 years
- letters of intent due 12 June 2024
- Supports initial exploration of innovative, high-risk, high-gain, and
potentially groundbreaking concepts in the tuberous sclerosis complex (TSC) research field. - preliminary data allowed but not required
- clinical trials not allowed
- Document – Funding Announcement: HT942524TSCRPEHDA_GG
Idea Development Award – HT942524TSCRPIDA
- up to USD$500,000 over 3 years
- letters of intent due 12 June 2024
- supports new ideas that have the potential to yield high-impact findings and new avenues of investigation
- New-to-the-Field Investigators Option available
- preliminary data expected
- clinical trials not allowed
- Document: Funding Announcement: HT942524TSCRPIDA_GG
Clinical Translational Research Award – HT942524TSCRPCTRA
- up to USD$1M or USD$1.15M (Partnering PI option) over 3 years
- letters of intent due 12 June 2024
- Supports studies that will move promising, well-founded preclinical and/or clinical research findings closer to clinical application, including diagnosis, prognosis or treatment.
- may include correlative studies that are associated with a completed clinical trial
- Studies advancing clinical trial readiness through the development of biomarkers,clinical endpoints and validation of pharmacokinetic/pharmacodynamics, as well as studies piloting clinical trials that include behavioral interventions, are of particular interest.
- may include a small pilot clinical trial intended to inform the next step
- pre-clinical studies may be appropriate but must include a clinical component
- Supports studies that encompass the analysis of existing real-world data practices to develop/improve guidelines for better outcomes in defined areas relevant to the focus areas of the program.
- exploratory and/or strictly animal research will not be supported
- collaboration between laboratory scientists and clinicians strongly encouraged
- preliminary data required
- Document – Funding Announcement: HT942524TSCRPCTRA__GG
